Characterization of the designer benzodiazepine pyrazolam and its detectability in human serum and urine

@article{Moosmann2013CharacterizationOT,
  title={Characterization of the designer benzodiazepine pyrazolam and its detectability in human serum and urine},
  author={Bjoern Moosmann and Melanie Hutter and Laura M. Huppertz and Sascha Ferlaino and Lisa Redlingsh{\"o}fer and Volker Auw{\"a}rter},
  journal={Forensic Toxicology},
  year={2013},
  volume={31},
  pages={263-271}
}
In 2012, online shops selling so-called research chemicals started offering pyrazolam, a new benzodiazepine that differs from phenazepam and etizolam, which have also recently appeared on the “gray market”, in that it is not marketed by pharmaceutical companies anywhere in the world. This article describes the characterization of pyrazolam (8-bromo-1-methyl-6-pyridin-2-yl-4H-[1,2,4]triazolo[4,3–a][1, 4]benzodiazepine) using gas chromatography-mass spectrometry, liquid chromatography-tandem mass… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 18 references

drug absorption, distribution, and elimination

  • Jenkins AJ Pharmacokinetics
  • Karch SB (ed) Drug abuse handbook. CRC Press…
  • 2013
1 Excerpt

Medikamente–Psychotrope und andere Arzneimittel mit Missbrauchs- und Abhängigkeitspotenzial

  • G Glaeske
  • Deutsche Hauptstelle für Suchtfragen (ed…
  • 2012

Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites

  • HH Maurer, K Pfleger, AA Weber
  • 2011
1 Excerpt

Similar Papers

Loading similar papers…